ArticleCardiovascular therapeutics2021
Eligibility of Dapagliflozin and Empagliflozin in a Real-World Heart Failure Population.
Erik Håkansson et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papertrialcites it